INTRODUCTION
The thymus is a common target organ for infectious pathogens. Viral, bacterial, and fungal infections of the thymus often result in severe atrophy, which can have marked consequences for the integrity and function of this crucial lymphoid organ (1) . In mice, influenza infection triggers extensive thymocyte apoptosis, causing atrophy of a large part of the gland (2) . In humans, the measles virus can also be potentially harmful to the thymus, infecting cortical thymic epithelial cells and affecting their function in T cell development (3). As described in several animal studies, viral infections of the thymus can interfere with central tolerance through the modulation of both positive and negative thymocyte selection (3) (4) (5) (6) . The recruitment of antimicrobial immunity directly to the thymus can help resolve local infection. For instance, it was reported that effector T cells specific to influenza (2) , lymphocytic choriomeningitis virus (7) , and Mycobacterium tuberculosis (8) homed to the thymus after infection and efficiently controlled the viral burden in the organ.
B cells are essential elements in the establishment of protective immunity to pathogens. The thymus contains a substantial subset of resident CD20 + B cells (9) . Although initially described as being mostly immunoglobulin M-positive (IgM + ) naïve B cells in mice (10, 11) , the normal human and mouse thymus also contains classswitched membrane IgG + cells (12) (13) (14) . The thymus is a highly dynamic organ that undergoes profound structural and functional changes throughout life. The size of the thymus progressively decreases with age together with its output of naïve T cells through a process known as thymic involution (15) . In addition to the cortex and medulla, the thymus also contains a third compartment called the perivascular space (PVS), which surrounds blood vessels within the capsule but is separate from the thymic epithelial space. This third compartment is often overlooked because it only represents a minimal area of the thymus during infancy and does not appear to be a site of thymopoiesis. However, as the thymus ages, the PVS enlarges and progressively replaces the epithelial area (16) . Although most studies have concluded that B cells are restricted to the medulla where they can participate in negative selection, Flores et al. (17) have shown that lymphoid cells, including B cells, are also present in the PVS. However, the function of PVS B cells has not been examined. We investigated whether B cells located in the thymic PVS include pathogen-specific clones. We present here a detailed analysis of the distribution, phenotype, and key functional aspects of human thymic B cells from 35 donors throughout seven decades of life. Our findings reveal an unrecognized role of the thymic PVS as a niche for viral antigen-reactive plasma cells (PCs). Because of its location at the interface between the circulation and the thymic epithelium, antigen-experienced B cells within this niche may confer protection to the thymus gland from a host of viruses.
RESULTS
The human thymus contains B cells in two distinct compartments: Medulla and PVS Previous studies have described abundant B cells in the medulla of the human thymus. An analysis of the distribution of B cells among thymic compartments using specimens from donors aged 5 days to 71 years showed that B cells were distributed throughout the thymic medulla, occupying 10 to 60% of the area in that compartment (Fig. 1A and figs. S1 and S2). In children older than 1 year, abundant clusters of B cells could also be detected in areas adjacent to but distinct from the medulla (Fig. 1A and fig. S1 ). In adults, where thymic morphology was showing evident signs of atrophy, B cells were abundantly distributed throughout the tissue where cortex and medulla could not be clearly defined (Fig. 1A and fig. S1 ). To determine the localization of these clustered B cells with greater accuracy, we performed immunofluorescence staining of the cytokeratin network. This staining allowed visualization of the cytokeratin + medullary thymic epithelial network and exposed the nonepithelial PVS ( fig. S3) . In all ages, we observed B cells colocalizing with cytokeratin + medullary thymic epithelial cells (mTECs). However, children older than 1 year and adults also contained prominent B cell clusters located in the nonepithelial areas of the thymus (Fig. 1B  and fig. S4 ), which appeared in early childhood and replaced most of the thymic epithelial areas in adults ( fig. S3 ). These well-defined nonepithelial areas correspond to the PVS, as evidenced by positive staining for the endothelial marker CD31 (PECAM-1) (Fig. 1B and fig. S5 ). The presence of CD20 + B cells in virtually all areas devoid of cytokeratin ( Fig. 1 and fig. S4 , children and adults) strongly suggested that these were located in the PVS. On the basis of the differences in the distribution of B cells and thymic morphology observed among donors ( fig. S1 ), we empirically defined three age groups for the remainder of the study: infants, 0 to 1 year (n = 15; actual range, 5 days to 11 months; median age, 3 months); children, 1 to 20 years (n = 13; actual range, 1.1 to 15 years; median age, 3 years); and adults, 20 to 60 years (n = 7; actual range, 27 to 71 years; median age, 40 years).
Memory B cells accumulate in the aging thymus
We next examined the phenotype of thymic B cells in relation to the age of the donors. The CD19 + B cell frequency among total thymocytes increased significantly from <5% in infants and children to 5 to 15% in adult thymuses ( Fig. 2A) . In infants, the vast majority of thymic B cells were naïve cells, with only a minimal fraction (2 to 15%) expressing the memory marker CD27. In children and adults, the frequency of CD27 + memory B cells significantly increased in an age-dependent manner, and this subset became predominant in the adult thymus (Fig. 2B) S6B ). The size of all thymic B cell subsets was different from that of the same subsets observed in the blood of healthy donors of the corresponding age (18) . We compared the frequency of memory B cells in the thymus and peripheral blood of adult donors from which matched blood samples were available. The proportion of class-switched IgG + and CD27 + memory B cells was significantly higher in the thymus compared with blood ( Fig. 2D) , indicating a tissue-specific enrichment of memory B cells rather than a reflection of circulating B cell subsets. Together, these data provide evidence of a previously overlooked group of B cells that accumulate in the thymic PVS, consistent with the accumulation of memory B cells in this organ.
Additionally, age-associated changes in the thymic B cell phenotype were not limited to the composition of naïve and memory B cells. Because previous studies in mice have shown that thymic B cells can present antigens to developing T cells in the medulla and contribute to negative selection, we also investigated the expression of molecules involved in this function, including major histocompatibility complex class II (MHC-II) and the costimulation molecules CD80, CD86 and CD83, and CD40. All molecules were highly expressed by thymic B cells from infant thymuses, but their expression decreased in B cells from older thymuses ( fig. S7A ). Moreover, we observed that CD19 + cells present in infant thymuses expressed significantly higher levels of MHC-II than CD11c dendritic cells isolated from the same specimens ( fig. S7 , B and C).
The aging thymus harbors antibody-producing PCs
In addition to memory B cells, we investigated whether the thymus might also harbor fully differentiated antibody-secreting PCs. This was examined by immunofluorescence staining of the adhesion proteoglycan CD138. Whereas PCs were scarcely detected in infant thymus, sections from child and adult specimens showed CD138 + cells that were clustered in cytokeratin-negative nonepithelial areas corresponding to the PVS (Fig. 3A and fig. S8 ). PCs within the PVS were also detected by staining of the secretory form of IgG in child and adult thymuses ( Fig. 3B and fig. S9 ). Simultaneous staining of CD20, CD138, and secretory IgG revealed that most CD138 + cells, which contained cytosolic IgG, had lost expression of CD20, consistent with the phenotype of terminally differentiated PCs (Fig. 3C) .
The persistence of PCs in the bone marrow is controlled by cellintrinsic mechanisms and the existence of nurturing cells, such as eosinophils, within the niche, which provide key external signals (19) . We asked whether any of these mechanisms were involved in the maintenance of thymic PCs. After hematoxylin and eosin staining, we observed the presence of PCs in proximity to eosinophils in all sections we analyzed from seven donors ranging from 3 to 39 years of age ( Fig. 4A and fig. S10 ). Moreover, we found that thymic PCs expressed CD28, which is known to promote the survival of bone marrow PCs (19) , at significantly higher levels compared with circulating PCs (Fig. 4B) .
We further confirmed the presence of functional PCs in the human thymus by examining their ability to secrete antibodies. IgM-, IgG-, and IgA-producing PCs were enumerated using enzymelinked immunospot (ELISpot) assay. Thymocytes from infants, children, and adults contained cells that spontaneously secreted IgM, IgG, and IgA, albeit at different ratios (Fig. 5A ), whereas few immunoglobulin-secreting cells were detected in unstimulated peripheral blood mononuclear cells (PBMCs) ( fig. S11 ). Infant thymuses contained predominantly IgM-secreting cells along with few IgGand IgA-secreting cells. In contrast, the frequency of IgM-secreting cells decreased among thymocytes from children and adults, which contained mostly IgGsecreting cells and, to a lesser extent, IgA-secreting cells (Fig. 5A ). To gain further insight into the functional properties of these antibodies, we analyzed the subclass profile of IgG secreted by thymic PCs. Most IgG-secreting cells produced IgG3 and, to a lesser extent, IgG1 (Fig.  5B ). These two IgG subclasses are the most abundant type of IgG produced in the course of viral infections and are most efficient at complement fixation and antibodydependent cellular cytotoxicity (20, 21) . No IgG2-or IgG4-secreting cells could be detected. In addition to fully differentiated PCs, we also found that the thymus contained plasmablasts identified as CD19 + cells expressing interferon regulatory factor 4 (IRF4), a key transcription factor driving the PC fate. As previously described, this factor is up-regulated at the plasmablast stage (22) . In most donors, plasmablasts represented less than 5% of total thymic B cells. However, in some cases, particularly among children close to 1 year of age, this subset was present at a significantly higher frequency (Fig. 5C ). CD19 + IRF4
+ cells also displayed high expression of CD27, consistent with a plasmablast phenotype ( fig. S12 ).
The thymus contains viral-specific PCs and memory B cells
Humoral immunity is maintained by pathogen-specific long-lived PCs residing primarily in the bone marrow. We reasoned that the newly identified pool of PCs maintained in the thymic PVS may also include pathogen-specific clones resulting from infectious experience or vaccination. To test this possibility, we assessed the frequency of IgGproducing PCs specific to prevalent viral pathogens and vaccine antigens among thymic B cells from infants younger than 12 months (n = 3; median age, 2 months) [thus before trivalent measles-mumps-rubella 
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(MMR) vaccination] and children aged 13 months to 15 years (n = 10; median age, 3 years). Antigen-specific ELISpots were carried out by coating plates with either viral immunodominant epitopes or wholevirus preparations of influenza, cytomegalovirus (CMV), Epstein-Barr virus (EBV), rhinovirus B, adenovirus C, measles, and rubella. Viral-specific cells were detected in multiple donors (Fig. 6, A and B) . The frequency of PCs specific to influenza and measles was significantly higher in children compared with infants (P < 0.01 and P < 0.05, respectively). Two of the three patients displaying a high response to measles [>5% of all antibody-secreting cells (ASCs)] also displayed a high response to rubella. However, because previous health information was not available for these patients, we could not relate the data to their vaccination history. Reactivity to EBV, adenovirus C, and rhinovirus B was also detected in few donors and did not show statistical difference between infants and children.
Because the thymus progressively accumulates memory B cells, we examined whether these cells could also provide an antiviral response upon reactivation. We found that after brief polyclonal stimulation, thymic memory B cells in children and adults acquired the phenotype of activated plasmablasts, up-regulating CD27, CD19, and the IRF4 transcription factor (Fig. 7A) . We tested the reactivity of IgG-producing activated memory B cells against the panel of antigens detailed previously and found that cells with antiviral specificity were also contained in this subset (Fig. 7, B and C) .
We next investigated whether a particular chemokine axis could have directed the homing of activated effector B cells to the thymus PVS. We analyzed the expression of the chemokine receptors CXCR3, CXCR4, and CXCR5, which are required for the recirculation of B cells through sites of inflammation, bone marrow, and lymphoid tissues (23) . Whereas CXCR4 and CXCR5 are expressed by virtually all thymic B cells regardless of age (Fig. 8, B and C) , the expression of CXCR3 showed a different pattern. Most thymic B cells in infants did not express CXCR3. However, a distinct CXCR3 + B cell subset appeared in the thymus of children and gradually increased with age (Fig. 8A) . These CXCR3 + cells were located within the PVS, as revealed by immunofluorescence (Fig. 8D) . median age, 28 years) and thymus (n = 5; median age, 3 years). Differences in CD28 expression were determined using one-way ANOVA (***P = 0.0001). Gating strategy of CD138 + PCs is shown in fig. S13 . MFI, mean fluorescence intensity.
DISCUSSION
Long considered an immunoprivileged site, the thymus is now recognized as a target of viral, bacterial, and parasitic infections. As shown in multiple animal studies, these infections can lead to thymic atrophy and reduce the overall thymopoiesis (3). Local viral-induced inflammatory reactions can also compromise the fine mechanisms of T cell selection, resulting in the export of improperly matured T cells in the periphery or the tolerance of new thymocytes toward the infecting agents (3). Although less studied, the consequences of thymic infections in humans are also detrimental. An example is measles infection. This viral infection is initiated in the respiratory tract and spreads systemically to multiple target organs, including the thymus. The viral tropism for thymic epithelial cells in the thymus results in severe thymocyte loss and immunosuppression (24) (25) (26) . For its central role in the development of T cell immunity, the thymus warrants efficient protective mechanisms against infections. The common view is that such protection is provided by serological immunity accrued through immunizations. Using a collection of thymus specimens from neonates to elderly donors, we reveal here an unknown characteristic of the human thymus and, more specifically, the PVS to house memory B cells and PCs with antiviral specificities. Because of its location, the PVS is a natural buffer zone between the circulation and the thymic cortex and medulla. Therefore, local production of viral-specific antibodies within this space represents an immune barrier to free viral particles. More generally, this unrecognized intrathymic B cell immunity is a likely natural defense against blood-borne pathogens. Evidence of B cells as a normal component of the thymus was reported more than four decades ago by the identification of an unusual subset of thymocytes that expressed surface immunoglobulin (27) . Subsequent characterization of human and mouse thymus confirmed the existence of thymic resident B cells confined to the medulla. In humans, thymic B cells have been investigated mainly in fetal and pediatric donors (9, 12, 28) . Likewise, studies in mice have been conducted using juvenile or young adults. As a result, the evolution of the thymic B cell population with age has not been thoroughly . Statistical differences in the frequency of viral-specific ASCs between both groups were determined using a Welch-corrected t test; P values are as follows: influenza, **P = 0.009; rubella, P = 0.64; CMV, P = 0.49; EBV, P = 0.20; measles, *P = 0.035; rhinovirus B, P = 0.91; adenovirus C, P = 0.50. fig. S7 ). This observation supports recent studies that have used transgenic mouse models with targeted presentation of foreign and self-antigen to demonstrate the contribution of thymic B cells to negative selection (13, 14, 29) , whereas other studies have pointed to their possible role in regulatory T cell differentiation (30, 31) .
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As revealed in our studies, the second subset of B cells starts to appear in the thymic PVS after the first year of life. The PVS enlarges with age, allowing an increasing number of B cells to accumulate in this area. PVS B cells include switched IgG + CD27 + memory cells together with terminally differentiated PCs primarily secreting IgG. We confirmed the function of the PCs by demonstrating their ability to spontaneously secrete antibodies ex vivo without the need for additional stimulation. This ability is characteristic of bone marrowresident PCs (32, 33) . In contrast, thymicderived memory B cells required in vitro stimulation during a 3-day culture to initiate antibody secretion. All classes of immunoglobulins, except IgE, are secreted by PVS B cells; however, IgG-secreting cells gradually become a predominant subset. Antibody production in the thymus has been documented in early studies in mice and pigs (34, 35) . However, our studies are the first to comprehensively characterize these cells in human thymic specimens in relation to reactivity and age.
The time of appearance of this second contingent of effector B cells in the thymic PVS appears to coincide with the ability to develop strong and persistent IgG antibody responses. Such humoral immunity is relatively weak during the first 12 months of life but progressively strengthens throughout childhood (36, 37) . The detection of high-frequency viral antigen-specific cells suggests that thymic memory B cells and PCs result from antiviral B cell responses elicited in early life. The predominance of IgG1 and IgG3 among IgG secreted by thymic PCs is consistent with such protective T celldependent humoral responses to pathogens and vaccine antigens (21, (38) (39) (40) (41) (42) . The increasing frequency of CXCR3 + thymic B cells, which localize in the PVS, also supports this view. The expression of this chemokine receptor is up-regulated on activated memory B cells and controls the migration of B cells to the bone marrow and sites of ongoing inflammation (23, 43, 44) . A comparable recruitment of pathogen-specific effector T cells expressing CXCR3 is observed in the mouse thymus during mycobacterial infection (8) . Collectively, these observations support the hypothesis that memory B cells and PCs accumulate in the PVS after peripheral immune responses and therefore reflect past immunization history.
Together, several lines of evidence support the existence of a PC niche in the aging human thymus: (i) the density of IgG-secreting, CD138 + PCs observed in the PVS is consistent with a specialized niche; (ii) the ability of thymic PCs to spontaneously secrete immunoglobulins without the need for additional stimulation in vitro is characteristic of fully differentiated long-lived PCs; (iii) the frequency of viral-specific PCs is comparable to that seen in bone marrow PC populations; (iv) the persistence of measles-and rubella-specific PCs in 3-, 6-, and 15-year-old donors (table S6) (i.e., years after the presumed time of MMR vaccination) suggests the presence of long-lived PCs; (v) eosinophils are detected in the thymic PVS in proximity to PCs [these polymorphonuclear cells are essential for the maintenance of long-lived PCs in the bone marrow (19) ]; (vi) thymic PCs express high levels of CD28, a necessary receptor required for the long-term maintenance of PCs and the bone marrow niche (45) . Whereas the thymic and bone marrow niche and PCs share a number of characteristics, it is also evident that they differ from others. For instance, the two niches have different anatomical locations, which may influence the function of their resident PCs. Our study has a number of limitations in part due to the difficulty of obtaining other tissue specimens from the same donors from whom we collected the thymus fragments. As a result, we could not compare thymic PCs with bone marrow or spleen PCs from the same individuals. Additionally, although the phenotypic and functional features of thymic PCs suggest their involvement in long-term protective immunity, we could not formally demonstrate this capacity.
Nevertheless, our observations raise several questions. First, is there a quantitative contribution of thymic PCs to the amount of serum immunoglobulins, particularly IgG? A comparison between the number of long-lived thymic PCs and that of the bone marrow could help evaluate this contribution. Although the volume of the bone marrow far outweighs that of the thymic tissue in adults, it is conceivable that this ratio be inverted during the first few years of life. Consequently, the infant thymus may represent a significant, even primary reservoir for PCs during this early life period. The second question is whether thymic PCs have a different repertoire of antigen specificities and therefore produce different immunoglobulins than bone marrow PCs. In this scenario, the contribution of thymic PCs would be more qualitative than quantitative.
In conclusion, we provide here evidence that pathogen-specific antibodyproducing PCs accumulate in the PVS of the human thymus. These cells are ideally poised to act as sentry against blood-borne infectious agents.
MATERIALS AND METHODS

Study design
The objective of this research study was to characterize the localization, phenotype, and functional properties of B cells located in the human thymus in relation to age. The working hypothesis was that thymic B cell subsets evolve with age in a manner consistent with their role. The study used thymus specimens collected randomly from pediatric and adult patients undergoing corrective heart surgery. A total of 35 specimens were collected from two separate institutions that were included in three age groups: infants (n = 15), children (n = 13), and adults (n = 7). The sample size was evaluated to provide sufficient statistical power to analyze all biological variables examined between the three age groups. None of the patients had a condition known to affect the immune system. Functional assays were carried out on a restricted number of samples because of cell availability. No randomization or blinding was used in this observational study. All data were reported, including outliers. All ELISpot assays were carried out in duplicates. fig. S14 ). Because the collected thymus was the discarded tissue from partial thymectomy performed during cardiac surgery, this study followed a nonhuman subject protocol approved by the MGH and Columbia University institutional review boards, respectively. Blood was also obtained from adult donors after informed consent.
Collection of human thymus
Sample processing
Thymic tissue was maintained in ice-cold phosphate-buffered saline (PBS) and processed immediately after removal. After extensive washing with PBS to remove blood, part of the tissue was fixed in a 10% paraformaldehyde solution and paraffin-embedded for histological analysis. The remaining tissue was disrupted and homogenized using a gentleMACS tissue dissociator (Miltenyi Biotec) and filtered through a 40-mm cell strainer (BD Biosciences). PBMCs from adult donors were isolated by Ficoll density gradient (GE Healthcare Life Sciences). Thymocyte and PBMC cell suspensions were frozen in heat-inactivated fetal bovine serum (FBS) (Atlanta Biologicals) supplemented with 10% dimethyl sulfoxide and kept in liquid nitrogen.
Immunohistochemistry and tissue immunofluorescence
Immunohistochemical and immunofluorescence stainings were performed on 4-mm-thick formalin-fixed, paraffin-embedded tissue sections. Sections were treated with xylene and graded alcohols, and antigen retrieval was performed in citrate buffer (Biocare Medical) using the Decloaking Chamber (Biocare Medical). Regular immunohistochemical staining was performed using the Cell and Tissue Mouse HRP Kit (R&D Systems) and counterstained with Mayer's hematoxylin (Sigma-Aldrich). For immunofluorescence, background staining was blocked with Background Sniper solution (Biocare Medical) after antigen retrieval. The following antibodies were used for immunohistochemistry and immunofluorescence: anti-human CD20 (L26, Dako), CD20 (BV11, Abcam), cytokeratin (AE1AE3, Abcam), CD31 (EPR3094, Abcam), CD138 (SP152, Abcam), secretory IgG (EPR4421, Abcam), and CXCR3 (1C6, Abcam). Primary antibodies were diluted in tris-buffered saline with 1% bovine serum albumin and incubated overnight at 4°C. For immunofluorescence, control stainings with fluorochromeconjugated secondary antibodies only are presented in fig. S15 .
(ANOVA) with Bonferroni multiple comparisons adjustments. Difference in the frequency of B cell subsets between patient-matched blood and thymus was tested using Student's paired t test.
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